Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SKW01 is a biological therapeutic developed by Skye Biologics, designed as an adjunct for knee repair. It is part of the company's "2nd Generation" of biological therapeutics, which utilize naturally advanced human biological materials to facilitate tissue repair and healing. The product is intended for regenerative medicine applications, specifically targeting musculoskeletal injuries and surgical adjuncts in the knee to promote healing and structural restoration. As a biological adjunct, it is typically used to enhance the biological environment during or after surgical procedures to improve patient outcomes in knee tissue repair.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SKW01.